Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LidoSite is a transdermal iontophoretic local anesthetic system that delivers lidocaine with epinephrine through the skin to produce localized dermal analgesia for procedures such as venipuncture and superficial dermatologic interventions. It uses a low-level electrical current to drive the charged anesthetic and vasoconstrictor into the skin, where lidocaine blocks voltage-gated sodium channels in peripheral nerves to inhibit impulse initiation and conduction, while epinephrine induces local vasoconstriction to prolong anesthetic duration and limit systemic absorption. Developed as a prescription topical anesthetic product combining established agents with a device-based delivery system, it was approved for short-term local anesthesia but is no longer marketed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on LidoSite.